Correlation Between Comera Life and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Comera Life and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Comera Life and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Comera Life Sciences and Processa Pharmaceuticals, you can compare the effects of market volatilities on Comera Life and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Comera Life with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Comera Life and Processa Pharmaceuticals.
Diversification Opportunities for Comera Life and Processa Pharmaceuticals
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Comera and Processa is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Comera Life Sciences and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Comera Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Comera Life Sciences are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Comera Life i.e., Comera Life and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Comera Life and Processa Pharmaceuticals
Given the investment horizon of 90 days Comera Life Sciences is expected to generate 0.49 times more return on investment than Processa Pharmaceuticals. However, Comera Life Sciences is 2.03 times less risky than Processa Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 58.00 in Comera Life Sciences on August 28, 2024 and sell it today you would earn a total of 8.00 from holding Comera Life Sciences or generate 13.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 4.24% |
Values | Daily Returns |
Comera Life Sciences vs. Processa Pharmaceuticals
Performance |
Timeline |
Comera Life Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Processa Pharmaceuticals |
Comera Life and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Comera Life and Processa Pharmaceuticals
The main advantage of trading using opposite Comera Life and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Comera Life position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.Comera Life vs. SAB Biotherapeutics | Comera Life vs. Processa Pharmaceuticals | Comera Life vs. Third Harmonic Bio | Comera Life vs. Indaptus Therapeutics |
Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |